Depression relief was the primary driver of disease improvement among patients with fibromyalgia and prominent anxiety and depression symptoms.

A considerable proportion of pregnant women are colonized with enterobacterales with ampicillin and ceftriaxone resistance in the US.

Higher insulin sensitivity was independently associated with a lower prevalence of RA, with obesity identified as a key mediator.

Efgartigimod alfa–hyaluronidase significantly improves ocular symptoms in adults with ocular myasthenia gravis, according to phase 3 trial data.

Exposure to low-credibility health content online is limited, but the likelihood of exposure increases with age.

COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia, according to a recent study.

Pregnancy and breastfeeding are associated with stronger long-term cognitive ability among postmenopausal women.

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

For individuals with high BP, baduanjin, a traditional Chinese mind-body practice, can lower systolic BP, with effects sustained for 1 year.

In a major shift, the US Food and Drug Administration is relaxing a long-standing drug approval requirement for common diseases.

Infection, comorbidities, renal pathologic features, male sex, and disease activity are risk factors for AKI among patients with LN.

In the United States, SLE remains associated with substantial mortality, particularly among Non-Hispanic Black women.